Fengjuan Fan
Fengjuan Fan
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany
1,2,
Stefano Malvestiti
Stefano Malvestiti
2Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany
2,
Sonia Vallet
Sonia Vallet
3Department of Internal Medicine II, University Hospital Krems, Krems an der Donau, Austria
4Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria
3,4,
Judith Lind
Judith Lind
4Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria
4,
Jose Manuel Garcia-Manteiga
Jose Manuel Garcia-Manteiga
5Center for Translational Genomics and Bioinformatics, IRCCS San Raffaele Scientific Institute, Milan, Italy
5,
Eugenio Morelli
Eugenio Morelli
6Department of Experimental and Clinical Medicine, University “Magna Græcia” of Catanzaro, Catanzaro, Italy
7Department of Medicine, Harvard Medical School, Boston, MA USA
6,7,
Qinyue Jiang
Qinyue Jiang
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1,
Anja Seckinger
Anja Seckinger
8University Hospital Heidelberg, Heidelberg, Germany
9Laboratory of Hematology and Immunology & Laboratory for Myeloma Research, Vrije Universiteit Brussel (VUB) Belgium, Brussels, Belgium
8,9,
Dirk Hose
Dirk Hose
8University Hospital Heidelberg, Heidelberg, Germany
9Laboratory of Hematology and Immunology & Laboratory for Myeloma Research, Vrije Universiteit Brussel (VUB) Belgium, Brussels, Belgium
8,9,
Hartmut Goldschmidt
Hartmut Goldschmidt
2Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany
8University Hospital Heidelberg, Heidelberg, Germany
2,8,
Andreas Stadlbauer
Andreas Stadlbauer
10Department of Neurosurgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany
11Institute of Medical Radiology, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria
10,11,
Chunyan Sun
Chunyan Sun
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1,
Heng Mei
Heng Mei
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1,
Martin Pecherstorfer
Martin Pecherstorfer
3Department of Internal Medicine II, University Hospital Krems, Krems an der Donau, Austria
3,
Latifa Bakiri
Latifa Bakiri
12Genes & Disease Group, Department of Dermatology, Medical University of Vienna (MUW), Vienna, Austria
12,
Erwin F Wagner
Erwin F Wagner
12Genes & Disease Group, Department of Dermatology, Medical University of Vienna (MUW), Vienna, Austria
13Genes & Disease Group, Department of Laboratory Medicine, Medical University of Vienna (MUW), Vienna, Austria
12,13,
Giovanni Tonon
Giovanni Tonon
5Center for Translational Genomics and Bioinformatics, IRCCS San Raffaele Scientific Institute, Milan, Italy
14Functional Genomics of Cancer Unit, Experimental Oncology Division, IRCCS San Raffaele Scientific Institute, Milan, Italy
5,14,
Martin Sattler
Martin Sattler
7Department of Medicine, Harvard Medical School, Boston, MA USA
15Department of Surgery, Brigham and Women’s Hospital, Boston, MA USA
7,15,
Yu Hu
Yu Hu
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1,✉,
Pierfrancesco Tassone
Pierfrancesco Tassone
6Department of Experimental and Clinical Medicine, University “Magna Græcia” of Catanzaro, Catanzaro, Italy
6,
Dirk Jaeger
Dirk Jaeger
2Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany
2,
Klaus Podar
Klaus Podar
2Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany
3Department of Internal Medicine II, University Hospital Krems, Krems an der Donau, Austria
4Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria
2,3,4,✉
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany
3Department of Internal Medicine II, University Hospital Krems, Krems an der Donau, Austria
4Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria
5Center for Translational Genomics and Bioinformatics, IRCCS San Raffaele Scientific Institute, Milan, Italy
6Department of Experimental and Clinical Medicine, University “Magna Græcia” of Catanzaro, Catanzaro, Italy
7Department of Medicine, Harvard Medical School, Boston, MA USA
8University Hospital Heidelberg, Heidelberg, Germany
9Laboratory of Hematology and Immunology & Laboratory for Myeloma Research, Vrije Universiteit Brussel (VUB) Belgium, Brussels, Belgium
10Department of Neurosurgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany
11Institute of Medical Radiology, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria
12Genes & Disease Group, Department of Dermatology, Medical University of Vienna (MUW), Vienna, Austria
13Genes & Disease Group, Department of Laboratory Medicine, Medical University of Vienna (MUW), Vienna, Austria
14Functional Genomics of Cancer Unit, Experimental Oncology Division, IRCCS San Raffaele Scientific Institute, Milan, Italy
15Department of Surgery, Brigham and Women’s Hospital, Boston, MA USA
Subject terms: Cell signalling, Myeloma
© The Author(s), under exclusive licence to Springer Nature Limited 2021
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
